Jawbone Cavitation Expressed RANTES/CCL5: Case Studies Linking Silent Inflammation in the Jawbone with Epistemology of Breast Cancer

References

• McAllisterF, BaileyJM, AlsinaJ, et al. Oncogenic kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia. Cancer Cell. 2014;25(5):621–637. doi:10.1016/j.ccr.2014.03.01424823639
   PubMed Web of Science ®Google Scholar
• KryczekI, LinY, NagarshethN, et al. IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L. Immunity. 2014;40(5):772–784. doi:10.1016/j.immuni.2014.03.01024816405
   PubMed Web of Science ®Google Scholar
• FerrarelliLK. Exosomes prep the metastatic site. Sci Signal. 2015;8(380):ec150 LP–ec150. doi:10.1126/scisignal.aac7366
   Google Scholar
• KhalidA, WolframJ, FerrariI, et al. Recent advances in discovering the role of CCL5 in metastatic breast cancer. Mini Rev Med Chem. 2015;15(13):1063–1072. doi:10.2174/13895575151315092309470926420723
   PubMed Web of Science ®Google Scholar
• ParkCC, BissellMJ, Barcellos-HoffMH. The influence of the microenvironment on the malignant phenotype. Mol Med Today. 2000;6(8):324–329. doi:10.1016/S1357-4310(00)01756-110904250
   PubMedGoogle Scholar
• BonafeM, StorciG, FranceschiC. Inflamm-aging of the stem cell niche: breast cancer as a paradigmatic example: breakdown of the multi-shell cytokine network fuels cancer in aged people. Bioessays. 2012;34(1):40–49. doi:10.1002/bies.20110010422086861
   PubMed Web of Science ®Google Scholar
• BiecheI, LereboursF, TozluS, EspieM, MartyM, LidereauR. Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature. Clin Cancer Res. 2004;10(20):6789–6795. doi:10.1158/1078-0432.CCR-04-030615501955
   PubMed Web of Science ®Google Scholar
• KohlmeierJE, MillerSC, SmithJ, et al. The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. Immunity. 2008;29(1):101–113. doi:10.1016/j.immuni.2008.05.01118617426
   PubMed Web of Science ®Google Scholar
• SchallTJ, BaconK, ToyKJ, GoeddelDV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature. 1990;347(6294):669–671. doi:10.1038/347669a01699135
   PubMed Web of Science ®Google Scholar
• LinC-L, SuriRM, RahdonRA, AustynJM, RoakeJA. Dendritic cell chemotaxis and transendothelial migration are induced by distinct chemokines and are regulated on maturation. Eur J Immunol. 1998;28(12):4114–4122. doi:10.1002/(SICI)1521-4141(199812)28:12<4114::AID-IMMU4114>3.0.CO;2-C9862347
   PubMed Web of Science ®Google Scholar
• RomagnaniS. Cytokines and chemoattractants in allergic inflammation. Mol Immunol. 2002;38(12–13):881–885. doi:10.1016/S0161-5890(02)00013-512009564
   PubMed Web of Science ®Google Scholar
• Velasco-VelazquezM, PestellRG. The CCL5/CCR5 axis promotes metastasis in basal breast cancer. Oncoimmunology. 2013;2(4):e23660. doi:10.4161/onci.2366023734321
   PubMed Web of Science ®Google Scholar
• WertelI, TarkowskiR, BednarekW, KotarskiJ. Relationship between RANTES and dendritic cells in ovarian cancer patients. Front Biosci. 2011;3:227–232. doi:10.2741/e237
   Google Scholar
• VadayGG, PeehlDM, KadamPA, LawrenceDM. Expression of CCL5 (RANTES) and CCR5 in prostate cancer. Prostate. 2006;66(2):124–134. doi:10.1002/pros.2030616161154
   PubMed Web of Science ®Google Scholar
• MontiP, MarchesiF, ReniM, et al. A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile. Virchows Arch. 2004;445(3):236–247. doi:10.1007/s00428-004-1053-x15258755
   PubMed Web of Science ®Google Scholar
• MrowietzU, SchwenkU, MauneS, et al. The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice. Br J Cancer. 1999;79(7–8):1025–1031. doi:10.1038/sj.bjc.669016410098731
   PubMed Web of Science ®Google Scholar
• LechnerJ. Validation of dental X-ray by cytokine RANTES – comparison of X-ray findings with cytokine overexpression in jawbone. Clin Cosmet Investig Dent. 2014;6:71–79. doi:10.2147/CCIDE.S69807
   Google Scholar
• BouquotJ, ShanklandWI, MargolisM. Through-transmission alveolar ultrasonography (TAU) – new technology for evaluation of bone density and desiccation. Comparison with radiology of 170 biopsied alveolar sites of osteoporotic and ischemic damage. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93:413–414.
   Google Scholar
• LechnerJ, von BaehrV. RANTES and fibroblast growth factor 2 in jawbone cavitations: triggers for systemic disease?Int J Gen Med. 2013;6:277–290. doi:10.2147/IJGM.S4385223637551
   PubMedGoogle Scholar
• von LuettichauI, NelsonPJ, PattisonJM, et al. RANTES chemokine expression in diseased and normal human tissues. Cytokine. 1996;8(1):89–98. doi:10.1006/cyto.1996.00128742071
   PubMed Web of Science ®Google Scholar
• LechnerJ, SchulzT, von BaehrV. Immunohistological staining of unknown chemokine RANTES/CCL5 expression in jawbone marrow defects—osteoimmunology and disruption of bone remodeling in clinical case studies targeting on predictive preventive personalized medicine. EPMA J. 2019;10(4):351–364. doi:10.1007/s13167-019-00182-131832111
   PubMed Web of Science ®Google Scholar
• SoriaG, Ben-BaruchA. The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett. 2008;267(2):271–285. doi:10.1016/j.canlet.2008.03.01818439751
   PubMed Web of Science ®Google Scholar
• NiwaY, AkamatsuH, NiwaH, SumiH, OzakiY, AbeA. Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res. 2001;7(2):285–289.11234881
   PubMed Web of Science ®Google Scholar
• WiglerN, ShinaS, KaplanO, et al. Breast carcinoma: a report on the potential usage of the CC chemokine RANTES as a marker for a progressive disease. Isr Med Assoc J. 2002;4(11 Suppl):940–943.12455185
   PubMed Web of Science ®Google Scholar
• ZhangY, LvD, KimH-J, et al. A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells. Cell Res. 2013;23(3):394–408. doi:10.1038/cr.2012.17823266888
   PubMed Web of Science ®Google Scholar
• LuboshitsG, ShinaS, KaplanO, et al. Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res. 1999;59(18):4681–4687.10493525
   PubMed Web of Science ®Google Scholar
• LasloP, SpoonerCJ, WarmflashA, et al. Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell. 2006;126(4):755–766. doi:10.1016/j.cell.2006.06.05216923394
   PubMed Web of Science ®Google Scholar
• KarnoubAE, DashAB, VoAP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 2007;449(7162):557–563. doi:10.1038/nature0618817914389
   PubMed Web of Science ®Google Scholar
• FerlayJ, SoerjomataramI, DikshitR, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi:10.1002/ijc.2921025220842
   PubMed Web of Science ®Google Scholar
• GregorMF, HotamisligilGS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29(1):415–445. doi:10.1146/annurev-immunol-031210-10132221219177
   PubMed Web of Science ®Google Scholar
• OsbornO, OlefskyJM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med. 2012;18(3):363–374. doi:10.1038/nm.262722395709
   PubMed Web of Science ®Google Scholar
• DuongMN, CleretA, MateraE-L, et al. Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity. Breast Cancer Res. 2015;17(1):57. doi:10.1186/s13058-015-0569-025908175
   PubMed Web of Science ®Google Scholar
• EichbaumC, MeyerA-S, WangN, et al. Breast cancer cell-derived cytokines, macrophages and cell adhesion: implications for metastasis. Anticancer Res. 2011;31(10):3219–3227.21965729
   PubMed Web of Science ®Google Scholar
• BaturcamE, AbubakerJ, TissA, et al. Physical exercise reduces the expression of RANTES and its CCR5 receptor in the adipose tissue of obese humans. Mediators Inflamm. 2014;2014:627150. doi:10.1155/2014/62715024895488
   PubMed Web of Science ®Google Scholar
• XiongY, RussellDL, McDonaldLT, CowartLA, LaRueAC. Hematopoietic stem cell-derived adipocytes promote tumor growth and cancer cell migration. Int J Cancer Res Mol Mech. 2017;3(1). doi:10.16966/2381-3318.130
   Google Scholar
• LechnerJ, von BaehrV. Hyperactivated signaling pathways of chemokine RANTES/CCL5 in osteopathies of jawbone in breast cancer patients-case report and research. Breast Cancer (Auckl). 2014;8:89–96. doi:10.4137/BCBCR.S1511924899812
   PubMedGoogle Scholar
• NiemanKM, RomeroIL, Van HoutenB, LengyelE. Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta. 2013;1831(10):1533–1541. doi:10.1016/j.bbalip.2013.02.01023500888
   PubMed Web of Science ®Google Scholar
• CarrollPA, HealyL, LysaghtJ, et al. Mammary adipose tissue and cancer cell growth: the role of adipose tissue in the tumor microenvironment. J Clin Oncol. 2009;27(15_suppl):e22009–e22009. doi:10.1200/jco.2009.27.15_suppl.e22009
   Google Scholar
• AndarawewaKL, MotrescuER, ChenardM-P, et al. Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/cross-talk at the tumor invasive front. Cancer Res. 2005;65(23):10862–10871. doi:10.1158/0008-5472.CAN-05-123116322233
   PubMed Web of Science ®Google Scholar
• IyengarP, CombsTP, ShahSJ, et al. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene. 2003;22(41):6408–6423. doi:10.1038/sj.onc.120673714508521
   PubMed Web of Science ®Google Scholar
• Zischek C, Niess H, Ischenko I, et al. Gezielte stammzellbasierte RANTES/Tk Suizidgentherapie des murinen Pankreaskarzinoms [Targeted stem cell based RANTES/TK suicide gene-therapy in a murine pancreatic cancer tumour model]. In: Schumpelick V, Bruch HP, Schackert HK, editors. Deutsche Gesellschaft für Chirurgie [German Society for Surgery], vol 38. Heidelberg: Springer, Berlin; 2009. German. doi:10.1007/978-3-642-00625-8_2
   Google Scholar
• Yaal-HahoshenN, ShinaS, Leider-TrejoL, et al. The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients. Clin Cancer Res. 2006;12(15):4474–4480. doi:10.1158/1078-0432.CCR-06-007416899591
   PubMed Web of Science ®Google Scholar
• CrossnoJTJ, MajkaSM, GraziaT, GillRG, KlemmDJ. Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells. J Clin Invest. 2006;116(12):3220–3228. doi:10.1172/JCI2851017143331
   PubMed Web of Science ®Google Scholar
• TomiyamaK, MuraseN, StolzDB, et al. Characterization of transplanted green fluorescent protein+ bone marrow cells into adipose tissue. Stem Cells. 2008;26(2):330–338. doi:10.1634/stemcells.2007-056717975222
   PubMed Web of Science ®Google Scholar
• SeraY, LaRueAC, MoussaO, et al. Hematopoietic stem cell origin of adipocytes. Exp Hematol. 2009;37(9):1108–1120, 1120.e1–4. doi:10.1016/j.exphem.2009.06.008
   Web of Science ®Google Scholar
• LechnerJ, von BaehrV. Chemokine RANTES/CCL5 as an unknown link between wound healing in the jawbone and systemic disease: is prediction and tailored treatments in the horizon?EPMA J. 2015;6(1):10. doi:10.1186/s13167-015-0032-425987906
   PubMed Web of Science ®Google Scholar
• RosenED, SpiegelmanBM. What we talk about when we talk about fat. Cell. 2014;156(1–2):20–44. doi:10.1016/j.cell.2013.12.01224439368
   PubMed Web of Science ®Google Scholar
• LiuS, DontuG, WichaMS. Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res. 2005;7(3):86–95. doi:10.1186/bcr102115987436
   PubMed Web of Science ®Google Scholar
• Picon-RuizM, PanC, Drews-ElgerK, et al. Interactions between adipocytes and breast cancer cells stimulate cytokine production and drive Src/Sox2/miR-302b-mediated malignant progression. Cancer Res. 2016;76(2):491–504. doi:10.1158/0008-5472.CAN-15-092726744520
   PubMed Web of Science ®Google Scholar
• BrombergJ, WangTC. Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell. 2009;15(2):79–80. doi:10.1016/j.ccr.2009.01.00919185839
   PubMed Web of Science ®Google Scholar
• FlorisI, LechnerJ, LejeuneB. Follow-up of patients with systemic immunological diseases undergoing fatty-degenerative osteolysis of the jawbone surgery and treated with RANTES 27CH. J Biol Regul Homeost Agents. 2018;32(1):37–45.
   Web of Science ®Google Scholar
• NicoliniA, CarpiA, RossiG. Cytokines in breast cancer. Cytokine Growth Factor Rev. 2006;17(5):325–337. doi:10.1016/j.cytogfr.2006.07.00216931107
   PubMed Web of Science ®Google Scholar
• MarquesRE, GuabirabaR, RussoRC, TeixeiraMM. Targeting CCL5 in inflammation. Expert Opin Ther Targets. 2013;17(12):1439–1460. doi:10.1517/14728222.2013.83788624090198
   PubMed Web of Science ®Google Scholar
• BussolinoF, MantovaniA, PersicoG. Molecular mechanisms of blood vessel formation. Trends Biochem Sci. 1997;22(7):251–256. doi:10.1016/S0968-0004(97)01074-89255066
   PubMed Web of Science ®Google Scholar
• SuffeeN, HlawatyH, Meddahi-PelleA, et al. RANTES/CCL5-induced proangiogenic effects depend on CCR1, CCR5 and glycosaminoglycans. Angiogenesis. 2012;15(4):727–744. doi:10.1007/s10456-012-9285-x22752444
   PubMed Web of Science ®Google Scholar
• AmbatiBK, AnandA, JoussenAM, KuzielWA, AdamisAP, AmbatiJ. Sustained inhibition of corneal neovascularization by genetic ablation of CCR5. Invest Ophthalmol Vis Sci. 2003;44(2):590–593. doi:10.1167/iovs.02-068512556387
   PubMed Web of Science ®Google Scholar
• EymanD, DamodarasamyM, PlymateSR, ReedMJ. CCL5 secreted by senescent aged fibroblasts induces proliferation of prostate epithelial cells and expression of genes that modulate angiogenesis. J Cell Physiol. 2009;220(2):376–381. doi:10.1002/jcp.2177619360811
   PubMed Web of Science ®Google Scholar
• TanJ, BuacheE, ChenardM-P, Dali-YoucefN, RioM-C. Adipocyte is a non-trivial, dynamic partner of breast cancer cells. Int J Dev Biol. 2011;55(7–9):851–859. doi:10.1387/ijdb.113365jt21948738
   PubMed Web of Science ®Google Scholar
• PittengerMF, MackayAM, BeckSC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–147. doi:10.1126/science.284.5411.14310102814
   PubMed Web of Science ®Google Scholar
• ChaturvediP, GilkesDM, TakanoN, SemenzaGL. Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment. Proc Natl Acad Sci U S A. 2014;111(20):E2120–9. doi:10.1073/pnas.140665511124799675
   PubMed Web of Science ®Google Scholar
• WhiteGE, IqbalAJ, GreavesDR. CC chemokine receptors and chronic inflammation – therapeutic opportunities and pharmacological challenges. Pharmacol Rev. 2013;65(1):47–89. doi:10.1124/pr.111.00507423300131
   PubMed Web of Science ®Google Scholar
• ZlotnikA, BurkhardtAM, HomeyB. Homeostatic chemokine receptors and organ-specific metastasis. Nat Rev Immunol. 2011;11(9):597–606. doi:10.1038/nri304921866172
   PubMed Web of Science ®Google Scholar
• MiZ, BhattacharyaSD, KimVM, GuoH, TalbotLJ, KuoPC. Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis. Carcinogenesis. 2011;32(4):477–487. doi:10.1093/carcin/bgr00921252118
   PubMed Web of Science ®Google Scholar
• WeigeltB, PeterseJL, van ’T VeerLJ. Breast cancer metastasis: markers and models. Nat Rev Cancer. 2005;5(8):591–602. doi:10.1038/nrc167016056258
   PubMed Web of Science ®Google Scholar
• MathotL, StenningerJ. Behavior of seeds and soil in the mechanism of metastasis: a deeper understanding. Cancer Sci. 2012;103(4):626–631. doi:10.1111/j.1349-7006.2011.02195.x22212856
   PubMed Web of Science ®Google Scholar
• KotyzaJ. Chemokines in tumor proximal fluids. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017;161(1):41–49. doi:10.5507/bp.2016.06228115749
   PubMed Web of Science ®Google Scholar
• BalkwillF. Cancer and the chemokine network. Nat Rev Cancer. 2004;4(7):540–550. doi:10.1038/nrc138815229479
   PubMed Web of Science ®Google Scholar
• LechnerJ, HueskerK, Von BaehrV. Impact of rantes from jawbone on chronic fatigue syndrome. J Biol Regul Homeost Agents. 2017;31(2):321–327.28685531
   PubMed Web of Science ®Google Scholar
• LechnerJ, SchuettS, von BaehrV. Aseptic-avascular osteonecrosis: local “silent inflammation” in the jawbone and RANTES/CCL5 overexpression. Clin Cosmet Investig Dent. 2017;9:99–109. doi:10.2147/CCIDE.S149545
   PubMed Web of Science ®Google Scholar